Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes

View/Open
Loveday_etal_ESMO_Analysis_of_Rare_VOR.pdf (619.0Kb)
Publication date
12/2022
Author
Metadata
Show full item record
Citation
Breast and Ovarian Cancer Susceptibility Collaboration 2022 , ' Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes ' , Annals of Oncology , vol. 33 , no. 12 , pp. 1318-1327 . https://doi.org/10.1016/j.annonc.2022.09.152
URI
https://hdl.handle.net/2164/20022
DOI
https://doi.org/10.1016/j.annonc.2022.09.152
Rights
0923-7534/© 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Collections